Blog - PipeBio

January 20, 2022 - PipeBio

Data Driven Decision Making in Biologics Drug Discovery

In biologics drug discovery, a biomolecule from its origins to the candidate drug status undergoes a variety of characterizations. Such characterizations are aimed to define the effectiveness, specificity, potency, adverse...
Read more >
September 28, 2021 - PipeBio

Nanobodies – A potent alternative

Introduction Biologic drugs are increasingly becoming important as therapeutics for treatment of various diseases, including cancer, infectious and inflammatory diseases. Classical antibody scaffolds and structures are being challenged by smaller...
Read more >
September 23, 2021 - PipeBio

Using Sanger sequences to fish for antibodies in large NGS repertoires

Introduction NGS is often used to explore the depths of the immune response against a given antigen and the cost of sequencing millions of antibodies is very low. The drawback...
Read more >
September 20, 2021 - PipeBio

Download Original files from PipeBio

When data is uploaded to PipeBio, we parse it and display the results to users. Sequence and related data can then be exported in a wide range of common bioinformatic...
Read more >
September 14, 2021 - PipeBio

Isogenica-PipeBio Collaboration Press Release

Isogenica announce deployment of the PipeBio Bioinformatic Cloud SEP 9, 2021 Isogenica today announce that they are deploying PipeBio’s bioinformatic cloud to accelerate their drug discovery efforts in the field of therapeutic...
Read more >
August 8, 2021 - CloudSecurityPipeBio

ISO 27001 Compliance in Life Science

PipeBio is the ISO 27001 certified bioinformatics cloud for antibody drug discovery and screening. Today we sat down with Reidar Poulsen of ProcessManager and learned about his job as an...
Read more >